Agomab Therapeutics NV (AGMB)

Agomab Therapeutics NV has filed 32 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.

Recent SEC filings

Form Date Description
6-K 2026-06-23 Report of Foreign Private Issuer
6-K 2026-05-27 Report of Foreign Private Issuer
SC 13G 2026-05-15 Beneficial Ownership Report (Passive)
SC 13G 2026-05-15 Beneficial Ownership Report (Passive)
6-K 2026-04-24 Report of Foreign Private Issuer
20-F 2026-04-23 Annual Report (Foreign)
SCHEDULE 13G 2026-04-16 SCHEDULE 13G
3 2026-03-18 Initial Statement of Beneficial Ownership
3 2026-03-18 Initial Statement of Beneficial Ownership
3 2026-03-18 Initial Statement of Beneficial Ownership